M&A

Specter Of Murky Past Means Valeant Could Be Sold For Scrap
Seeking Alpha
Fri, 11/11/16 - 09:42 am
Valeant Pharmaceuticals
M&A
Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit
TheStreet.com
Thu, 11/10/16 - 12:27 pm
Pfizer
consumer health
M&A
Sanofi
GSK
JNJ
Gilead Sciences: 5 Reasons to Buy Alexion…and 4 Reasons It Shouldn’t
Barron's
Tue, 11/8/16 - 04:44 pm
Gilead Sciences
Alexion
M&A
FDA warns Valeant over production problems caused by acquisitions
Stat
Tue, 11/8/16 - 04:40 pm
FDA
Valeant Pharmaceutcals
M&A
Gilead Sciences: No M&A, No Pipeline?
Barron's
Mon, 11/7/16 - 09:13 pm
Gilead Sciences
M&A
Abbott looks to mollify EU regulators on St. Jude Medical merger; sues Alere for breach of contract
Mass Device
Fri, 11/4/16 - 09:35 am
Abbott Labs
devices
Europe
St. Jude Medical
Alere
M&A
More Valeant up for bid? Beseiged pharma weighs $2.5B sale of eye-surgery biz
Fierce Pharma
Thu, 11/3/16 - 09:52 am
Valeant Pharmceuticals
M&A
Bausch & Lomb
eye surgery
Celldex Acquires Cancer Medicine Company for $62.5 Million
Yahoo
Thu, 11/3/16 - 09:44 am
Celldex Therapeutics
M&A
Kolton Pharmaceuticals
Should Valeant Shareholders Be Content With The Firesale Beginning?
Seeking Alpha
Thu, 11/3/16 - 09:41 am
Valeant Pharmaceuticals
M&A
Salix
What would a Salix sale do for Valeant?
BioPharma Dive
Wed, 11/2/16 - 10:26 pm
Salix
Valeant Pharmaceutcals
M&A
Gilead Sciences: Is an Acquisition the Right Prescription?
Barron's
Wed, 11/2/16 - 10:22 pm
Gilead Sciences
M&A
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Reuters
Wed, 11/2/16 - 11:04 am
Valeant Pharmaceuticals
Salix
M&A
Takeda
Allergan Successfully Completes Tobira Therapeutics Acquisition
Yahoo
Tue, 11/1/16 - 04:53 pm
Allergan
Tobira Therapeutics
M&A
Astellas furthers oncology focus with Ganymed buy
BioPharma Dive
Fri, 10/28/16 - 05:48 pm
Astellas
oncology
Ganymed
M&A
IMAB362
gastroesophageal cancer
Drugmaker Sanofi hungry for deals after earnings beat
Yahoo/Reuters
Fri, 10/28/16 - 10:14 am
Sanofi
M&A
earnings
St. Jude Medical’s shareholders OK $25B Abbott buyout
Mass Device
Thu, 10/27/16 - 10:23 pm
Abbott Labs
St. Jude Medical
M&A
devices
Allergan’s executive team orchestrates a $200M buyout to beef up gastroenterology pipeline
Endpoints
Thu, 10/27/16 - 09:22 am
Allergan
M&A
relamorelin
diabetic gastroparesis
Merck and Novartis chiefs outline what’s on the M&A menu in 2017
Endpoints
Wed, 10/26/16 - 09:14 am
Merck
Novartis
M&A
Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal
Endpoints
Tue, 10/25/16 - 09:54 am
Shire
myelofibrosis
CTI BioPharma
Baxalta
M&A
pacritinib
With no big M&A on tap, Novartis presses pause on $12B-plus Roche stake sale
Fierce Pharma
Mon, 10/24/16 - 11:51 pm
Novartis
M&A
Roche

Pages